Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Cash from Operations: 2016-2025

Historic Cash from Operations for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to $78.4 million.

  • Collegium Pharmaceutical's Cash from Operations rose 971.63% to $78.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $290.9 million, marking a year-over-year increase of 50.21%. This contributed to the annual value of $205.0 million for FY2024, which is 25.39% down from last year.
  • Collegium Pharmaceutical's Cash from Operations amounted to $78.4 million in Q3 2025, which was up 8.28% from $72.4 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Cash from Operations registered a high of $99.7 million during Q2 2023, and its lowest value of -$25.3 million during Q1 2022.
  • Moreover, its 3-year median value for Cash from Operations was $72.4 million (2025), whereas its average is $62.4 million.
  • Per our database at Business Quant, Collegium Pharmaceutical's Cash from Operations slumped by 223.07% in 2022 and then soared by 971.63% in 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Cash from Operations (Quarterly) stood at $36.2 million in 2021, then spiked by 83.23% to $66.3 million in 2022, then climbed by 10.57% to $73.3 million in 2023, then climbed by 15.42% to $84.6 million in 2024, then soared by 971.63% to $78.4 million in 2025.
  • Its Cash from Operations stands at $78.4 million for Q3 2025, versus $72.4 million for Q2 2025 and $55.4 million for Q1 2025.